Recurrence rate of liver diseases discussed

Two-day conference on liver cancer organised by the Department of Hepatology, Post Graduate Institute of Medical Education and Research, in collaboration with the Department of Gastroenterology, AIIMS, New Delhi, concluded on Sunday. The seminar being held under the aegis of Indian National Association for the Study of Liver (INASL) and Current Perspective in Liver Diseases (CPLD) -2012 covered various aspects of liver diseases.

The second day of the conference began with a session on Hepatitis C Virus infection (HCV), where the problems of treatment of HCV infection with advanced liver disease, including patients with cirrhosis liver was discussed by Dr Ajit Sood from Dayanand Medical College and Hospital, Ludhiana. He also highlighted the high recurrence rate and problems of treatment of HCV infection in the post liver transplant period.

Dr Pankaj Puri from Command Hospital, Pune, elaborated on the newly emerging oral treatment for patients with HCV infection in the Indian setting. Other sessions included management of liver related side effects caused due to use of drugs to cure tuberculosis. The recent break through research in the field of Hepatology in the last one year was discussed by Dr Rakesh Aggarwal from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow.

Causes of increasing cases of fatty-liver diseases in India owing to obesity and diabetes were discussed at a symposium on non-alcoholic fatty liver disease (NAFLD). Over the years, NAFLD has become an important cause of chronic liver disease leading to liver cancer, and it has limited treatment options.

Please read our terms of use before posting comments
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
comments powered by Disqus